Literature DB >> 10581726

Antibacterial activities of anthozoan corals on some marine microfoulers.

V Wilsanand1, A B Wagh, M Bapuji.   

Abstract

The antibacterial activities of twelve species of anthozoans (4 gorgonians, 5 soft corals and 3 antipatharians) collected off the east coast of India were assayed against four dominant marine fouling bacterial strains isolated from the biofilm of fouled aluminium panels. Of the 48 combinations (12 corals x 4 bacteria) eighteen interactions showed antibacterial activity (37.5%). Such activity was most apparent in gorgonians, which inhibited bacterial growth in ten out of sixteen interactions (62.5%) compared with that of five out of twenty interactions (25%) among soft corals and three out of twelve interactions (25%) among antipatharians. The activity scores varied with different extracts and test organisms used, and was highest in antipatharians. Among the four bacterial strains Vibrio sp. was the least sensitive (2/12) when compared with Flavobacterium sp. (6/12). This is the first report of antibacterial activities of antipatharian colonies against marine microfoulers. The results imply that anthozoan corals harbour potent agents which could be exploited for the development of antifouling technology.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10581726

Source DB:  PubMed          Journal:  Microbios        ISSN: 0026-2633


  3 in total

1.  Comparative genomics of Paracoccus sp. SM22M-07 isolated from coral mucus: insights into bacteria-host interactions.

Authors:  Camila Carlos; Letícia Bianca Pereira; Laura Maria Mariscal Ottoboni
Journal:  Curr Genet       Date:  2016-10-31       Impact factor: 3.886

2.  In situ oxygen dynamics in coral-algal interactions.

Authors:  Daniel Wangpraseurt; Miriam Weber; Hans Røy; Lubos Polerecky; Dirk de Beer; Maggy M Nugues
Journal:  PLoS One       Date:  2012-02-02       Impact factor: 3.240

3.  Use of Quorum Sensing Inhibition Strategies to Control Microfouling.

Authors:  Andrea Muras; Ana Parga; Celia Mayer; Ana Otero
Journal:  Mar Drugs       Date:  2021-01-30       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.